Kelly Dunn

Mar 20, 2024 | thelancet.com | Kelly Dunn |Eric Strain

1. Institute for Health Metrics and EvaluationGlobal Burden of Disease Study 2017 (GBD 2017) data resources. 2. Degenhardt L Grebely J Stone J et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019; 394: 1560-15793. State-level economic costs of opioid use disorder and fatal opioid overdose—United States, 2017. MMWR Morb Mortal Wkly Rep. 2021; 70: 541-5464.

Mar 12, 2024 | jamanetwork.com | Jennifer M. Whitehill |Kelly Dunn |Johns Hopkins |Renee Johnson

The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products In this issue of JAMA, a study by Harlow and colleagues found that 11% of US high school seniors (ie, 12th grade) reported using Δ8-tetrahdyrocannabinol (Δ8-THC) in the past 12 months based on a 2023 survey.1 This study is a reminder that there is a diverse set of cannabis products on the market that vary in their legal and regulatory status and potential for harm.2-5 Δ8-THC is a psychoactive cannabinoid that can...

Dec 19, 2023 | onlinelibrary.wiley.com | Kelly Dunn |Andrew S. Huhn |Patrick Finan |Ami Mange

1 INTRODUCTION Only 12% of the estimated >10 million persons in the United States who report lifetime use of an opioid develop opioid use disorder (OUD),1 suggesting only a subgroup of persons who are exposed to opioids develop problematic opioid use behaviours.2 To date, there have been limited evaluations of opioid response profiles; however, existing clinical reports3 and laboratory studies4-7 suggest that some individuals demonstrate dose-dependent responses to opioids whereas other...